Komaki, Ritsuko
The University of Texas MD Anderson Cancer Center · University of Washington · Huntsman Cancer Institute · University of Alabama at Birmingham · Dana-Farber Brigham Cancer Center · UCSF Helen Diller Family Comprehensive Cancer Center · Moores Cancer Center · Duke Cancer Institute
5 papers on CoChatORCID 0000-0003-0084-6017
Most cited papers
- Verified
Non–Small Cell Lung Cancer, Version 6.2015
Ettinger, D. S., Wood, D. E., Akerley, W., Bazhenova, L. A., Borghaei, H., Camidge, D. R., Cheney, R. T., Chirieac, L. R., D’Amico, T. A., Demmy, T. L., et al. (2015) · Journal of the National Comprehensive Cancer Network
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment
Cited by 478
- Verified
Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer
Welsh, J. W., Komaki, R., Amini, A., Munsell, M. F., Unger, W., Allen, P. K., Chang, J. Y., Wefel, J. S., McGovern, S. L., Garland, L. L., et al. (2013) · Journal of Clinical Oncology
Brain Metastases and TreatmentLung Cancer Treatments and Mutations
Cited by 395
- Verified
A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320
Sperduto, P. W., Wang, M., Robins, H. I., Schell, M. C., Werner-Wasik, M., Komaki, R., Souhami, L., Buyyounouski, M. K., Khuntia, D., Demas, W., et al. (2013) · International Journal of Radiation Oncology*Biology*Physics
Brain Metastases and TreatmentGlioma Diagnosis and Treatment
Cited by 274
- Verified
Stereotactic ablative radiotherapy: a potentially curable approach to early stage multiple primary lung cancer
Chang, J. Y., Liu, Y., Zhu, Z., Welsh, J. W., Gomez, D. R., Komaki, R., Roth, J. A., & Swisher, S. G. (2013) · Cancer
Lung Cancer Diagnosis and TreatmentAdvanced Radiotherapy Techniques
Cited by 91
- Verified
RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM).
Gilbert, M. R., Dignam, J., Won, M., Blumenthal, D. T., Vogelbaum, M. A., Aldape, K. D., Colman, H., Chakravarti, A., Jeraj, R., Armstrong, T. S., et al. (2013) · Journal of Clinical Oncology
Glioma Diagnosis and TreatmentAngiogenesis and VEGF in Cancer
Cited by 70
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free